This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Atherosclerosis Cardiovascular Disease Risk Factors 
Cardiometabolic Health Congress
JANUARY 16, 2025
Atherosclerosis (ASVD) remains a leading driver of cardiovascular disease (CVD), a global health challenge that claims millions of lives each year. Explore actionable, evidence-based strategies to combat traditional and emerging risk factors, with a focus on precision approaches and primordial prevention.
Open Heart
FEBRUARY 11, 2025
Background Left ventricular (LV) mass is closely associated with atherosclerotic heart disease, but the mechanisms are not well defined. This study aimed to evaluate the risk factors associated with LV mass and subclinical coronary atherosclerosis, in an Asian population free of baseline cardiovascular disease.
Science Daily - Heart Disease
SEPTEMBER 18, 2024
Metal exposure from environmental pollution is associated with increased calcium buildup in the coronary arteries at a level comparable to traditional risk factors, according to a new study.
Frontiers in Cardiovascular Medicine
APRIL 3, 2025
In recent years, the incidence of cardiovascular disease (CVD) has risen steadily, significantly impacting public health. Subclinical hypothyroidism (SCH) remains a controversial risk factor for CVD.
Dr. Paddy Barrett
FEBRUARY 27, 2024
And plaque in your coronary arteries is the result of exposure to risk factors over time. These individuals then must have had one or more risk factors for a long time prior to their heart attack. 2 You will not know you have heart disease by waiting for symptoms. The answer: Risk Factors.
111 
Cardiovascular Diabetology
APRIL 8, 2025
Preeclampsia (PE) and type 1 diabetes (T1D) are significant risk factors for cardiovascular disease (CVD), but their combined effect on atherosclerosis progression has not been fully explored. This study aimed.
American College of Cardiology
JUNE 25, 2024
Do autoimmune diseases independently correlate with coronary atherosclerosis and atherosclerotic cardiovascular disease (ASCVD) risk, and do traditional cardiovascular risk factors modulate the risk?
Frontiers in Cardiovascular Medicine
APRIL 24, 2025
Atherosclerosis (AS), a chronic inflammatory disease, remains a leading contributor to cardiovascular morbidity and mortality. Targeting this pathway offers a promising therapeutic strategy to reduce the burden of cardiovascular diseases (CVD).
Cardiovascular Diabetology
JANUARY 5, 2024
Findings from earlier research have established that insulin resistance (IR) is implicated in atherosclerosis progression, representing a noteworthy risk factor for cardiovascular disease (CVD). Recently, the.
Journal of Clinical Investigation - Cardiology
OCTOBER 1, 2024
Clonal hematopoiesis of indeterminate potential (CHIP) has emerged as a previously unrecognized, potent, age-related, and common risk factor for atherosclerosis. The increased risk of developing hematologic malignancy does not, on its own, explain excess mortality in individuals with CHIP.
DAIC
FEBRUARY 3, 2025
This clearance comes in advance of disease-modifying therapies on the horizon expected to help clinicians use this biomarker to guide patients to improved cardiovascular health, saidBrad Moore, president and CEO at Roche Diagnostics North America. The development of the Tina-quant Lipoprotein (a) Gen.2 J Clin Lipidol. 2024.03.001.
Dr. Paddy Barrett
DECEMBER 13, 2024
When it comes to cardiovascular disease, two of the biggest risk factors we must consider are: ApoB concentration - A measure of the number of circulating lipid particles. ApoB Atherosclerosis, by definition, is caused by the retention of an ApoB lipid particle in the artery wall. But only moderately.
American College of Cardiology
FEBRUARY 14, 2024
The risk of atherosclerotic cardiovascular disease (ASCVD) is approximately twofold higher for South Asian (SA) adults than for adults from other racial and ethnic groups. Type 2 diabetes mellitus (T2DM) is a highly prevalent risk factor that likely contributes to this disparity.
64 
Cardiovascular Diabetology
FEBRUARY 20, 2025
Dysglycaemia is a known risk factor for cardiovascular disease and microcirculatory dysfunction is associated with an increased cardiovascular disease risk. The aim of this study was to investigate the prevale.
JAMA Cardiology
NOVEMBER 5, 2024
Aortic stenosis (AS) due to fibrosis and calcification of the aortic valve is a hazardous component of cardiovascular disease burden—after developing symptomatic AS, patients survive for an average of less than 2 years without treatment.
Open Heart
MAY 31, 2022
Background Hepatocyte growth factor (HGF) is a biomarker with potential for use in the diagnosis, treatment and prognostication of cardiovascular disease (CVD). We used Poisson and linear mixed-effects regression models to estimate the association between HGF and ECC, adjusted for sociodemographic and CVD risk factors.
Circulation
NOVEMBER 11, 2024
Background:The role of immune suppressive microenvironment, promulgated by the presence of Myeloid Derived Suppressor Cells (MDSC) have been the major focus of research delineating the underlying mechanisms of cardiovascular diseases (CVD). 3ng/day for 15 days).M-MDSCs
Cardiometabolic Health Congress
JULY 25, 2024
Here’s what you can expect at the biggest conference in cardiorenal metabolic health, the 19th Annual Cardiometabolic Congress (CMHC), DECODING THE CONSTELLATION of Cardiometabolic Health and Risk Factors. Michos, MD, MHS, FACC, FAHA, FASE, FASPC ; famed hypertension expert Keith C.
100 
American College of Cardiology
SEPTEMBER 18, 2024
cobalt, copper, zinc) are associated with increased coronary artery calcification (CAC) and are comparable to traditional cardiovascular disease risk factors like smoking and diabetes, according to results from the Multi-Ethnic Study of Atherosclerosis (MESA) published in JACC.
The British Journal of Cardiology
AUGUST 1, 2024
Genome-wide association and Mendelian randomisation studies have identified lipoprotein(a) (Lp[a]) as an emerging risk factor for calcific aortic stenosis and a causal risk factor for atherosclerotic cardiovascular disease (ASCVD) in different ethnicities.
40 
Circulation: Heart Failure
MARCH 8, 2024
The prevalence of HF risk factors was high: hypertension, 61.9%; former or current smoking, 53.7%; obesity 34.8%; diabetes; 24.7%; and chronic kidney disease; 22%. Overt cardiovascular disease, which ranged from 2.1% (HF) to 13.6% (atrial fibrillation), was less common. were female, 25.6% were Black, 12.8%
Physiologically Speaking
JANUARY 5, 2024
Exercise prevents and reverses cardiovascular disease, but whether high-intensity exercise training (HIIT) is safe and effective for adults after minimally invasive heart surgery is unknown. Exercise is a wonder drug for cardiovascular disease (CVD) prevention and reversal. Cardiac rehab works wonders.
119 
DAIC
JULY 25, 2024
“We are encouraged by the implementation of our AI cardiac solution at esteemed healthcare systems, along with the continued validation through real-world studies of its potential to promote early detection and preventive care of cardiovascular disease,” said Erez Meltzer, Nanox Chief Executive Officer and Acting Chairman. “We
105 
Frontiers in Cardiovascular Medicine
MARCH 4, 2024
Atherosclerotic coronary artery disease (CAD) is the causal pathological process driving most major adverse cardiovascular events (MACE) worldwide. The complex development of atherosclerosis manifests as intimal plaque which occurs in the presence or absence of traditional risk factors.
59 
Cardiometabolic Health Congress
AUGUST 23, 2024
Updated with the latest research since the 2020 edition, this comprehensive report underscores the potential to prevent or significantly delay dementia by targeting modifiable risk factors. The report now identifies 14 modifiable risk factors for dementia.
52 
Stroke Journal
FEBRUARY 1, 2024
Background:The association between left ventricular injury (LVI) detected by cardiac magnetic resonance imaging (CMR) and the risk of a subsequent ischemic stroke is unknown.Methods:We studied stroke-free participants in the Multi-Ethnic Study of Atherosclerosis study who underwent a steady-state free precession CMR at Exam 5 (2010-2012).
Circulation: Cardiovascular Imaging
FEBRUARY 19, 2024
Circulation: Cardiovascular Imaging, Volume 17, Issue 2 , Page e015712, February 1, 2024. BACKGROUND:Coronary artery calcium computed tomography (CAC) is an important tool for identifying subclinical atherosclerosis and cardiovascular risk stratification. Most patients in both groups were White (95.2% versus 38.1%;P<0.001);
58 
Stroke Journal
NOVEMBER 9, 2023
The identification of a variant in theHDAC9gene as a risk factor for large-artery atherosclerotic stroke, and subsequently coronary artery disease, has opened novel treatment pathways for stroke and more widely atherosclerotic disease. Stroke, Volume 54, Issue 12 , Page 3182-3189, December 1, 2023.
40 
Open Heart
AUGUST 30, 2023
Introduction The independent and causal cardiovascular disease risk factor lipoprotein(a) (Lp(a)) is elevated in >1.5 billion individuals worldwide, but studies have prioritised European populations. Causal effects of increased Lp(a) with increased glycated haemoglobin were estimated for Europeans (p value =1.4
Heart BMJ
MARCH 22, 2024
Immune-mediated inflammatory diseases (IMIDs) are recognised risk factors for accelerated atherosclerotic cardiovascular disease (CVD), particularly in younger individuals and women who lack traditional CVD risk factors.
40 
Journal of the American Heart Association
DECEMBER 19, 2024
BackgroundElevated lowdensity lipoprotein cholesterol is a risk factor for atherosclerotic cardiovascular disease, including acute ischemic stroke (AIS), due to large and smallvessel disease.
40 
The British Journal of Cardiology
AUGUST 1, 2024
Lipoprotein(a) (Lp[a]) can improve the accuracy of assessment of atherosclerotic cardiovascular disease and the risk of aortic valve stenosis. Management of high levels encourages rigorous attention to correction of other risk factors, such as blood pressure, smoking and low-density lipoprotein (LDL).
40 
GEMMS
NOVEMBER 22, 2023
By understanding the significance of cardiovascular health, we can make informed choices and adopt lifestyle habits that promote a strong and resilient heart. Risk factors for cardiovascular disease Understanding the risk factors for cardiovascular disease is crucial for maintaining optimal cardiovascular health.
Coronary Artery Disease Journal
DECEMBER 1, 2024
Background Lipoprotein(a) [Lp(a)] is an independent risk factor for cardiovascular disease due to its unique apo(a) component and its association with atherosclerosis and thrombogenesis.
Circulation: Cardiovascular Quality & Outcomes
OCTOBER 18, 2023
We introduce a methodology and a framework used for preprocessing and harmonizing variables from multiple studies.RESULTS:We provide a real-case study and step-by-step guidance to demonstrate the practical utility of our repository and interactive web page.
Cardiometabolic Health Congress
AUGUST 14, 2024
Themed “Decoding the Constellation of Cardiometabolic Health and Risk Factors,” this year’s congress will tackle the growing health threat posed by cardiometabolic diseases, affecting 47 million people in the US. Shapiro, DO Back By Popular Demand!
72 Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Risk factors such as smoking, chronic kidney disease, and aging can contribute to plaque formation. The gradual loss of elasticity in arterial walls and the presence of other risk factors, such as high blood pressure and diabetes, contribute to the increased risk of cardiovascular disease (CVD) observed in aging populations.
40 
Dr. Paddy Barrett
AUGUST 22, 2023
However Most people do not appreciate that being a carrier of APOE4 significantly increases the risk of cardiovascular disease also. Share For those with defective LDL receptors, as seen in familial hyperlipidemia, APOB particles are not cleared effectively, and concentrations rise, causing atherosclerosis 4. 7 Ashiq, S.,
52 
Dr. Paddy Barrett
OCTOBER 31, 2023
An elevated Lp(a) is a common genetic factor that is independently and causally related to premature coronary artery disease. But we must always remember that most genetic risk factors are probabilistic rather than deterministic in terms of risk. Atherosclerosis. 2017 Jan;256:47-52.
Dr. Smith's ECG Blog
NOVEMBER 15, 2023
See "Mechanisms of acute coronary syndromes related to atherosclerosis".) See "Prevention of cardiovascular disease events in those with established disease (secondary prevention) or at very high risk".) Optical coherence tomography, due to its high resolution, may provide additional information [ 10,13 ].
Cardiometabolic Health Congress
JANUARY 15, 2025
Atherosclerosisa key driver of cardiovascular disease (CVD)continues to be a significant global health issue. While advances in treatment have reduced mortality in some regions, the atherosclerosis prevention remains challenging. Urbanization, increased sedentary lifestyles, and unhealthy diets have fueled this trend.
DAIC
MARCH 31, 2025
mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease. mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heart disease, said Matthew J.
DAIC
JANUARY 23, 2024
Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3
DAIC
FEBRUARY 1, 2024
February 1, 2024 — As cardiologists, heart disease patients and the organizations that serve them across the country embark on American Heart Month, DAIC has compiled a snapshot of significant cardiovascular disease (CVD) and stroke statistics, along with a review of the atherosclerosis drug market. per 1,000* - 122.4
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content